Therapeutic Botulinum Toxin | Market Insights | Global | 2024
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand among new patients driven by expanding indications.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for therapeutic BTX in the US, Europe, and the Asia Pacific region from 2019 through 2032.